Lara I. Silverman, Ph.D.
Affiliations: | 2011 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Biomedical EngineeringGoogle:
"Lara Silverman"Parents
Sign in to add mentor| Robert L. Mauck | grad student | 2011 | Penn | |
| (Enhancing meniscus repair through biomaterial design.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rodriguez-Granrose D, Zurawski J, Heaton W, et al. (2021) Transition from static culture to stirred tank bioreactor for the allogeneic production of therapeutic discogenic cell spheres. Stem Cell Research & Therapy. 12: 455 |
| Silverman LI, Heaton W, Farhang N, et al. (2020) Perspectives on the Treatment of Lumbar Disc Degeneration: The Value Proposition for a Cell-Based Therapy, Immunomodulatory Properties of Discogenic Cells and the Associated Clinical Evaluation Strategy. Frontiers in Surgery. 7: 554382 |
| Farhang N, Silverman LI, Bowles RD. (2020) Improving Cell Therapy Survival and Anabolism in Harsh Musculoskeletal Disease Environments. Tissue Engineering. Part B, Reviews |
| Silverman LI, Dulatova G, Tandeski T, et al. (2019) In Vitro and In Vivo Evaluation of Discogenic Cells, An Investigational Cell Therapy for Disc Degeneration. The Spine Journal : Official Journal of the North American Spine Society |
| Hiraishi S, Schol J, Sakai D, et al. (2018) Discogenic cell transplantation directly from a cryopreserved state in an induced intervertebral disc degeneration canine model. Jor Spine. 1: e1013 |
| Smith LJ, Silverman L, Sakai D, et al. (2018) Advancing cell therapies for intervertebral disc regeneration from the lab to the clinic: Recommendations of the ORS spine section. Jor Spine. 1: e1036 |
| Silverman LI, Dulatova G, Gupta K, et al. (2015) 655. Comparative Viability, Potency and In Vivo Efficacy of a Fresh or Cryopreserved Cell Therapy for the Treatment of Degenerative Disc Disease Molecular Therapy. 23 |
| Gupta K, Dulatova G, Tandeski T, et al. (2015) 407. Sensitivity and Reproducibility of a Metabolic Assay for Quality Control of Cell Therapy Lots Molecular Therapy. 23 |